Apixaban is a safe and effective alternative to warfarin in patients with end-stage renal disease on dialysis, resulting in fewer bleeding events.
Does apixaban reduce bleeding events compared to warfarin in patients with ESRD maintained on dialysis?
Apixaban may be a safer alternative to warfarin with fewer bleeding events in ESRD patients on dialysis.
Absolute Event Rate: 0% vs 0%
Compared to warfarin, our findings suggest that apixaban is a safe and effective alternative in patients with ESRD maintained on dialysis, with apixaban patients experiencing fewer bleeding events than warfarin patients.
Reed et al. (Mon,) reported a other. Apixaban is a safe and effective alternative to warfarin in patients with end-stage renal disease on dialysis, resulting in fewer bleeding events.